About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Diabetes Clinical Trials in Dallas | 16 Studies

Clinical Trials DiabetesDallas

Diabetes Clinical Trials in Dallas

Find 16 clinical trials for diabetes near Dallas, Texas. Connect with research centers in your area.

All Diabetes trials nationwide All trials in Dallas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-16 of 16 trials

CompletedSafety of Inhaled Insulin With Type 1 and Type 2 DiabetesPulmonary Safety in Diabetics with T/INCT00308737·Phoenix, Arizona and 175 others

Diabetes Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesThe purpose of this study is to evaluate the safety and effectiveness of alogliptin combined with metformin, once daily (QD) or twice daily (BID), in participants with Type 2…NCT01023581·Dothan, Alabama and 200 others

CompletedAfrezza® INHALE-1 Study in PediatricsINHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the efficacy and safety of Afrezza in combination with a basal insulin (i.e., the Afrezza group) versus…NCT04974528·Los Angeles, California and 38 others

Active not recruitingEversense® Non-adjunctive Use Post Approval StudyThis is a non-blinded, prospective, multi-center, single arm longitudinal cohort study (patient serving as their own control), to evaluate the effectiveness of diabetes with the…NCT04836546·Los Angeles, California and 22 others

CompletedClinical Trial of SB-509 in Subjects With Diabetic NeuropathyThe purpose of the study is to evaluate the clinical effects of the investigational drug, SB-509, in subjects with diabetic neuropathy.NCT01079325·Phoenix, Arizona and 30 others

CompletedClinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusThis open-label, multicenter study is designed to investigate the clinical utility and safety of pramlintide treatment in subjects with type 1 and type 2 diabetes who are failing…NCT00108004·Anaheim, California and 47 others

TerminatedPulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166The purpose of this study is to evaluate pulmonary function test (PFT) sub-study in interested subjects from studies MKC-TI-161, MKC-TI-162 and MKC-TI-166.NCT01201928·Fresno, California and 13 others

CompletedTreatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesThe purpose of this protocol is to determine if an investigational drug is effective in treating nerve malfunction in diabetes.NCT00044395·Mesa, Arizona and 38 others

CompletedEvaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & ThiazolidinedioneThe purpose of this study is to assess the efficacy and safety of Amaryl when added to Metformin and Thiazolidinedione (TZD) in non-insulin dependent diabetes mellitus (NIDDM)…NCT00044447·Dallas, Texas

TerminatedA Study in Participants With Diabetic Kidney DiseaseThe purpose of this study is to determine if LY2382770 is safe and effective at protecting kidney function in participants with kidney disease due to diabetes.NCT01113801·Phoenix, Arizona and 77 others

CompletedA 2-Month Safety Follow-Up TrialThe main purpose of the trial is to evaluate pulmonary function in subjects who had completed any one of the 4 MKC parent trials (MKC-TI-009, MKC-TI-102, MKC-TI-103, or…NCT00741429·Birmingham, Alabama and 149 others

CompletedEfficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in DiabeticsThis trial is conducted in the United States of America (USA).NCT00773279·Burlingame, California and 64 others

CompletedA Prospective, Randomized, Parallel Crossover Study Demonstrating Subject Wearability and Usability of the I-Port Injection PortThis study investigated wearability and usability of the I-PORT™ Injection Port (I-PORT™), a new disposable injection port through which prescribed medication is injected…NCT00486109·Atlanta, Georgia and 4 others

CompletedComparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin GlarginePrimary Objective: To demonstrate non-inferiority of SAR341402 versus NovoLog/NovoRapid in glycated hemoglobin A1c (HbA1c) change from baseline to Week 26 in participants with…NCT03211858·Little Rock, Arkansas and 81 others

CompletedPhase 2 Study of INV-202 in Patients With Diabetic Kidney DiseaseThe study is designed to assess the efficacy, safety, tolerability, and transformation within the human body of INV-202 investigational drug in the treatment of adult participants…NCT05514548·Garden Grove, California and 71 others

TerminatedEvaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary DiseaseExamine the effects of TI in combination with an anti-diabetic regimen including inhaled insulin versus anti-diabetic treatment without inhaled insulin on lung function \&…NCT00642616·Mission Hills, California and 20 others

Other Conditions in Dallas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia